Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2013092612695N1Phase 3Completed
Phase 3 trial of ketamine and bupivacaine in nephrolithiasis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Analgesic effectiveness. Started Mar 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2013092612695N1.